Darrell Wadas
Gastroenterology · Payson, AZNPI 1871565739
Payments from drug & device makers
Across 532 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$765
- Takeda Pharmaceuticals U.S.A., Inc.$746
- Gilead$536
- Pfizer$344
- plus $3K from 31 others
What the payments were for
- Food & beverage$10,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 148 | $3,198 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 107 | $1,755 |
| Johnson & Johnson | 39 | $765 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $746 |
| Gilead | 29 | $536 |
| Pfizer | 25 | $344 |
| E.r. Squibb & Sons, L.L.C. | 3 | $336 |
| Bristol Myers Squibb | 18 | $310 |
| Nestle Healthcare Nutrition Inc. | 16 | $303 |
| Redhill Biopharma Inc. | 11 | $253 |
| QOL Medical, LLC | 15 | $251 |
| Ferring Pharmaceuticals Inc. | 13 | $229 |
| Ardelyx, Inc. | 9 | $195 |
| Sanofi | 7 | $167 |
| Shionogi Inc | 9 | $139 |
| Ironwood Pharmaceuticals, Inc | 7 | $106 |
| Merck | 6 | $101 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Braintree Laboratories, Inc. | 4 | $58 |
| Intercept Pharmaceuticals, Inc. | 3 | $56 |
| Shire North American Group Inc | 3 | $39 |
| Boston Scientific | 2 | $37 |
| UCB, Inc. | 2 | $32 |
| Intra-sana Laboratories | 2 | $32 |
| Alfasigma USA, Inc. | 2 | $30 |
| Mylan Institutional Inc. | 1 | $26 |
| Abbott | 1 | $25 |
| Lucid Diagnostics Inc. | 1 | $24 |
| Fresenius Kabi USA, LLC | 1 | $23 |
| Olympus America Inc. | 1 | $21 |
| Organon | 1 | $20 |
| Evoke Pharma, Inc. | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Echosens North America, Inc. | 1 | $9 |
| Gastrogpo, LLC | 4 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,340 in reported general payments places this provider in the 65th percentile of 355 gastroenterology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 56 | $1,374 |
| Pantoprazole Sodium | 78 | $1,015 |
| Omeprazole | 33 | $647 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Payson
- Joseph DavisChandler$7.4M
- Sam MoussaTucson$3.9M
- Manreet KaurScottsdale$2.5M
- Bassel KissoTucson$2.3M
- Fadi DeebTucson$1.5M
- Chirag TrivediSun City$954K
- Joel BrillParadise Valley$850K
- Daniel MelineScottsdale$795K
- Moises Nevah RubinPhoenix$763K
- Sasha TalebanTucson$744K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.